-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00-41.46% Downside
Gracell Biotechnologies Inc. Frequently Asked Questions
-
What analysts cover Gracell Biotechnologies Inc.?
Gracell Biotechnologies Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.